Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.

Abu-Amer Y, Darwech I, Otero J.

Autoimmunity. 2008 Apr;41(3):204-11. doi: 10.1080/08916930701694543. Review.

PMID:
18365833
2.

Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis.

Clohisy JC, Roy BC, Biondo C, Frazier E, Willis D, Teitelbaum SL, Abu-Amer Y.

J Immunol. 2003 Nov 15;171(10):5547-53.

4.

NF-kappaB modulators in osteolytic bone diseases.

Xu J, Wu HF, Ang ES, Yip K, Woloszyn M, Zheng MH, Tan RX.

Cytokine Growth Factor Rev. 2009 Feb;20(1):7-17. doi: 10.1016/j.cytogfr.2008.11.007. Epub 2008 Nov 28. Review.

PMID:
19046922
5.

Role of nuclear factor-kappaB in the immune system and bone.

Jimi E, Ghosh S.

Immunol Rev. 2005 Dec;208:80-7. Review.

PMID:
16313342
6.

NF-kappaB activation and inhibition: a review.

Sun Z, Andersson R.

Shock. 2002 Aug;18(2):99-106. Review.

PMID:
12166787
7.

Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss in athymic nude mice.

Sung B, Murakami A, Oyajobi BO, Aggarwal BB.

Cancer Res. 2009 Feb 15;69(4):1477-84. doi: 10.1158/0008-5472.CAN-08-3249. Epub 2009 Feb 3.

8.

Notch is activated in RANKL-induced osteoclast differentiation and resorption.

Duan L, de Vos P, Fan M, Ren Y.

Front Biosci. 2008 May 1;13:7064-71.

PMID:
18508716
9.

Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.

Wilson TJ, Nannuru KC, Futakuchi M, Sadanandam A, Singh RK.

Cancer Res. 2008 Jul 15;68(14):5803-11. doi: 10.1158/0008-5472.CAN-07-5889.

10.

A nuclear factor-kappaB inhibitor BAY11-7082 inhibits interactions between human endothelial cells, T cells, and monocytes.

Zhu B, Liu Z, Wang P, Wu C, Xu H.

Transplant Proc. 2008 Oct;40(8):2724-8. doi: 10.1016/j.transproceed.2008.07.129.

PMID:
18929846
11.

Fos/AP-1 proteins in bone and the immune system.

Wagner EF, Eferl R.

Immunol Rev. 2005 Dec;208:126-40. Review.

PMID:
16313345
12.

Baicalein inhibits osteoclast differentiation and induces mature osteoclast apoptosis.

Kim MH, Ryu SY, Bae MA, Choi JS, Min YK, Kim SH.

Food Chem Toxicol. 2008 Nov;46(11):3375-82. doi: 10.1016/j.fct.2008.08.016. Epub 2008 Aug 26.

PMID:
18786594
13.

Gene expression profiling of human alveolar macrophages infected by B. anthracis spores demonstrates TNF-alpha and NF-kappab are key components of the innate immune response to the pathogen.

Dozmorov M, Wu W, Chakrabarty K, Booth JL, Hurst RE, Coggeshall KM, Metcalf JP.

BMC Infect Dis. 2009 Sep 10;9:152. doi: 10.1186/1471-2334-9-152.

14.

IL-23 induces receptor activator of NF-kappaB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model.

Ju JH, Cho ML, Moon YM, Oh HJ, Park JS, Jhun JY, Min SY, Cho YG, Park KS, Yoon CH, Min JK, Park SH, Sung YC, Kim HY.

J Immunol. 2008 Jul 15;181(2):1507-18.

15.

Advances in osteoclast differentiation and function.

Abu-Amer Y.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Sep;5(3):347-55. Review.

PMID:
16178795
16.

Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.

Uwe S.

Biochem Pharmacol. 2008 Apr 15;75(8):1567-79. Epub 2007 Nov 4. Review.

PMID:
18070616
17.

Modulation of osteoclast function in bone by the immune system.

Quinn JM, Saleh H.

Mol Cell Endocrinol. 2009 Oct 30;310(1-2):40-51. doi: 10.1016/j.mce.2008.11.002. Epub 2008 Nov 14. Review.

PMID:
19056462
18.

Treatment with N-tosyl-l-phenylalanine chloromethyl ketone after the onset of collagen-induced arthritis reduces joint erosion and NF-kappaB activation.

Choi J, Ha KH, Byun MS, Min SY, Park MJ, Park HS, Oh HJ, Ju JH, Kim HY, Jue DM.

Eur J Pharmacol. 2008 Oct 24;595(1-3):108-13. doi: 10.1016/j.ejphar.2008.07.056. Epub 2008 Jul 31.

PMID:
18706406
19.

Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.

Mori Y, Tsuji S, Inui M, Sakamoto Y, Endo S, Ito Y, Fujimura S, Koga T, Nakamura A, Takayanagi H, Itoi E, Takai T.

J Immunol. 2008 Oct 1;181(7):4742-51.

20.

Anti-inflammatory effects of plumbagin are mediated by inhibition of NF-kappaB activation in lymphocytes.

Checker R, Sharma D, Sandur SK, Khanam S, Poduval TB.

Int Immunopharmacol. 2009 Jul;9(7-8):949-58. doi: 10.1016/j.intimp.2009.03.022. Epub 2009 Apr 15.

PMID:
19374955

Supplemental Content

Support Center